Daylla 3 mg/0,02 mg filmom obložene tablete
| Name | Daylla 3 mg/0,02 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-320765811 |
| Active Substance | drospirenon etinilestradiol |
| Composition | jedna filmom obložena tableta sadrži 3 mg drospirenona i 0,02 mg etinilestradiola |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Gedeon Richter Plc., Budimpešta, Mađarska |
| Marketing Authorisation Holder | Gedeon Richter Plc., Gyömrői út 19-21, Budimpešta, Mađarska |
| Marketing Authorisation Date | 12.02.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/18-02/272 |
| Registration Number | 381-12-01/70-21-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G03AA12 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for healthcare professionals |
Lista provjere za propisivača verzija 1 |
| Educational materials for patients / caregivers |
Važne informacije za korisnice, verzija 1.1 |
